Ropeginterferon alfa-2b, a novel IFNО±-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Gisslinger, H, Zagrijtschuk, O, Buxhofer-Ausch, V, Thaler, J, Schloegl, E, Gastl, GA, Wolf, D, Kralovics, R, Gisslinger, B, Strecker, K, Egle, A, Melchardt, T, Burgstaller, S, Willenbacher, E, Schalling, M, Them, NC, Kadlecova, P, Klade, C, Greil, R.

http://www.ncbi.nlm.nih.gov/pubmed/26261238